We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 8 July, become the first regulator in the world to approve elinzanetant (Lynkuet) for the treatment of moderate to severe vasomotor symptoms (hot flushes) associated with the menopause.
As with all products, the MHRA will keep its safety under close review.
Information for local authorities on training and standardisation for moderators of key stages 2 (KS2) English writing.
This rapid review is an update of a report on nutrition interventions in developing and fragile contexts from 2014
Study examined the interrelation between prevention and treatment of moderate acute malnutrition (MAM) on children aged 6–23 months
18 men participated in a 6-week controlled consumption study of a low-zinc, rice-based diet
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).